Palvella Therapeutics (PVLA) Exchange Rate Effect (2014 - 2026)
Palvella Therapeutics (PVLA) reported Exchange Rate Effect of -$15000.0 for Q1 2026, down 150.0% year-over-year from $30000.0 in Q1 2025, and up 97.54% quarter-over-quarter from -$610000.0 in Q4 2025.
Palvella Therapeutics (PVLA) Exchange Rate Effect (2014 - 2026) Analysis & Trends
Palvella Therapeutics (PVLA) has 13 years of Exchange Rate Effect data on file, last reported at -$15000.0 in Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at -$15000.0, down 150.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $37000.0 (up 1333.33% YoY), and the FY2025 annual result was $46000.0, up 1433.33% from the prior year.
- Exchange Rate Effect climbed to -$15000.0 in Q1 2026 per PVLA's latest filing, from -$610000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $1.9 million in Q4 2022 and troughed at -$3.3 million in Q2 2022.
- A 5-year average of -$367214.3 and a median of -$45000.0 in 2023 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect soared 315.39% in 2022, then tumbled 20433.33% in 2025.
- A 5-year view of Exchange Rate Effect shows it stood at $1.9 million in 2022, then tumbled by 103.86% to -$75000.0 in 2023, then surged by 104.0% to $3000.0 in 2024, then plunged by 20433.33% to -$610000.0 in 2025, then surged by 97.54% to -$15000.0 in 2026.
- Business Quant data shows PVLA's Exchange Rate Effect at -$15000.0 in Q1 2026, -$610000.0 in Q4 2025, and $770000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Palvella Therapeutics | 1.49 Bn | 1.23 Bn | - | -15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15,000.00 |
| Mar 31, 2026 | -15,000.00 |
| Dec 31, 2025 | -610,000.00 |
| Dec 31, 2025 | -610,000.00 |
| Sep 30, 2025 | 770,000.00 |
| Sep 30, 2025 | 770,000.00 |
| Jun 30, 2025 | -108,000.00 |
| Jun 30, 2025 | -108,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Dec 31, 2023 | -75,000.00 |
| Dec 31, 2023 | -75,000.00 |
| Sep 30, 2023 | -337,000.00 |
| Sep 30, 2023 | -337,000.00 |
| Jun 30, 2023 | 212,000.00 |
| Jun 30, 2023 | 212,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Mar 31, 2023 | 200,000.00 |